The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma

scientific article published on 25 August 2011

The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/GENE.2011.59
P932PMC publication ID3876733
P698PubMed publication ID21866115
P5875ResearchGate publication ID51594479

P50authorFranco AversaQ45309228
Herlander MarquesQ47101515
Fernando RodriguesQ47314443
Cristina CunhaQ47314450
Artur PaivaQ47805899
Lucia PitzurraQ52008085
Margarida SaraivaQ56523280
Patricia MacielQ30429831
Luigina RomaniQ37386517
Rui MedeirosQ38327360
Paula LudovicoQ42592637
Jorge PedrosaQ42651247
P2093author name stringM Gomes
P Heutink
A Carvalho
C F Skibola
P M Bracci
A C Pinto
F Torres
L Conde
J F Lacerda
A J Almeida
A Marques
P Tavares
E Torrado
M G da Silva
N S Osório
M Di Ianni
A G Castro
A G Gomes-Alves
M Teixeira-Coelho
N Domingues
P Rendeiro
S Pedreiro
P2860cites workIncrease in NF-kappaB binding affinity of the variant C allele of the toll-like receptor 9 -1237T/C polymorphism is associated with Helicobacter pylori-induced gastric diseaseQ42910227
Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas.Q42987134
Viruses and lymphomasQ43038788
Putative association of a TLR9 promoter polymorphism with atopic eczema.Q43693434
Helicobacter pylori-associated gastritis and primary B-cell gastric lymphomaQ44824307
Polymorphisms and haplotypes in TLR9 and MYD88 are associated with the development of Hodgkin's lymphoma: a candidate-gene association study.Q45888335
Crohn's disease is associated with a toll-like receptor-9 polymorphismQ47243561
Polymorphisms in Toll‐Like Receptor Genes and Susceptibility to Pulmonary AspergillosisQ56837281
TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohortQ57154996
Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case–control disease association studies☆☆This work was supportedQ57253814
Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantationQ58855378
Study of disease-relevant polymorphisms in the TLR4 and TLR9 genes: A novel method applied to the analysis of the Portuguese populationQ59200021
Toll-like receptor (TLR)-9 promotor polymorphisms and atherosclerosisQ81122508
B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotidesQ81474815
Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphomaQ21562611
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptorsQ27860900
Measurement of the human allele frequency spectrum demonstrates greater genetic drift in East Asians than in EuropeansQ28705866
NF-kappaB in cancer: from innocent bystander to major culpritQ29614603
Toll-like receptors: critical proteins linking innate and acquired immunityQ29615190
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptideQ29619485
Genetic susceptibility to lymphomaQ33641328
Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphomaQ33663837
Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?Q33811658
Comprehensive genetic assessment of a functional TLR9 promoter polymorphism: no replicable association with asthma or asthma-related phenotypesQ33821390
Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cellsQ33931707
Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individualsQ34056881
Pathogenesis of Sjögren's syndromeQ34212469
Borrelia infection and risk of non-Hodgkin lymphomaQ34275054
CpG motifs in bacterial DNA trigger direct B-cell activationQ34307394
Global cancer statistics in the year 2000.Q34571897
Toll-like receptors in systemic autoimmune diseaseQ34576448
Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiologyQ35916377
Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphomaQ36447972
Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitisQ36497063
Altered immunity as a risk factor for non-Hodgkin lymphomaQ36751495
Autoimmune and inflammatory disorders and risk of malignant lymphomas--an updateQ37328554
The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cellsQ38355683
Immunoproliferative small intestinal disease associated with Campylobacter jejuniQ38449266
Toll-like receptors and CD14 genes polymorphisms and susceptibility to asthma in Tunisian children.Q39155912
P433issue2
P921main subjecttoll-like receptorQ408004
non-Hodgkin lymphomaQ1138590
P304page(s)197-201
P577publication date2011-08-25
P1433published inGenes and ImmunityQ15745246
P1476titleThe rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma
P478volume13

Reverse relations

cites work (P2860)
Q37527855Association between TLR-9 polymorphisms and colon cancer susceptibility in Saudi Arabian female patients
Q50056654B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors
Q98386581CD markers polymorphisms as prognostic biomarkers in hematological malignancies
Q47681393Discovery and application of immune biomarkers for hematological malignancies.
Q92314002Functional Polymorphisms and Gene Expression of TLR9 Gene as Protective Factors for Nasopharyngeal Carcinoma Severity and Progression
Q26768522Global Plant Stress Signaling: Reactive Oxygen Species at the Cross-Road
Q36137122Inherited Inflammatory Response Genes Are Associated with B-Cell Non-Hodgkin's Lymphoma Risk and Survival
Q38516259Inherited variation in immune response genes in follicular lymphoma and diffuse large B-cell lymphoma
Q36060845Involvement of Toll-like Receptor 9 polymorphism in cervical cancer development
Q37111066Polymorphism in the promoter region of the Toll-like receptor 9 gene and cervical human papillomavirus infection
Q98205267TLR4 896A/G and TLR9 1174G/A polymorphisms are associated with the risk of infectious mononucleosis
Q35996996TLR9 -1486T/C and 2848C/T SNPs Are Associated with Human Cytomegalovirus Infection in Infants
Q90369286TLR9 Polymorphisms Might Contribute to the Ethnicity Bias for EBV-Infected Nasopharyngeal Carcinoma
Q36071989TLR9 agonists induced cell death in Burkitt's lymphoma cells is variable and influenced by TLR9 polymorphism
Q38449562TLR9 gene polymorphism (rs187084, rs352140): association with acute rejection and estimated glomerular filtration rate in renal transplant recipients
Q34088209The C allele of rs5743836 polymorphism in the human TLR9 promoter links IL-6 and TLR9 up-regulation and confers increased B-cell proliferation
Q31131769The TLR9 gene polymorphisms and the risk of cancer: evidence from a meta-analysis
Q39378247Toll-like receptor 2 and 9 genetic polymorphisms and the susceptibility to B cell Non-Hodgkin Lymphoma in Egypt.
Q36382348Toll-like receptors and human disease: lessons from single nucleotide polymorphisms
Q38948266Toll-like receptors targeting technology for the treatment of lymphoma
Q42969291Trial Watch: Toll-like receptor agonists for cancer therapy
Q33878578Trial Watch: Toll-like receptor agonists in oncological indications
Q40885153Variations in genes involved in regulation of the nuclear factor - κB pathway and the risk of acute myeloid leukaemia

Search more.